Panacea Index Logo

Command Palette

Search for a command to run...

Massage therapy for patients with metastatic cancer: a pilot randomized controlled trial.

Journal of alternative and complementary medicine (New York, N.Y.)
July 1, 2013
Maria Toth et al. (6 authors)
Journal ArticleRandomized Controlled TrialResearch Support, N.I.H., ExtramuralHuman StudyClinical
Study Details

Study Goal

The researchers aimed to determine the feasibility and effects of providing therapeutic massage at home for patients with metastatic cancer, comparing massage therapy to no-touch intervention and usual care.

Results Summary

The study found that therapeutic massage improved quality of life after 1 week, though the effect was not sustained at 1 month. Trends toward improvement in pain and sleep were observed in the massage group but not in control groups, with no serious adverse events reported.

Population

Patients with metastatic cancer.

Effective Dosage

Mean of 2.8 massage therapy sessions per patient.

Duration

1-week follow-up, with some outcomes assessed at 1 month.

Interactions

None mentioned.

Extracted Claims (7)
InterventionDirectionEndpointPopulationDosageImpactClaim #
massage therapy
increase
quality of life
patients with metastatic cancer
-
A significant improvement was found
#1
massage therapy
increase
pain
patients with metastatic cancer
-
trends toward improvement
#2
massage therapy
increase
sleep
patients with metastatic cancer
-
trends toward improvement
#3
No Touch control
no change
quality of life
patients with metastatic cancer
-
not observed
#4
Usual Care control
no change
quality of life
patients with metastatic cancer
-
not observed
#5
massage therapy
no change
quality of life
patients with metastatic cancer
-
difference was not sustained
#6
massage therapy
no change
adverse events
patients with metastatic cancer
-
no serious adverse events related
#7
Abstract

OBJECTIVES: The study objectives were to determine the feasibility and effects of providing therapeutic massage at home for patients with metastatic cancer. DESIGN: This was a randomized controlled trial. SETTINGS/LOCATION: Patients were enrolled at Oncology Clinics at a large urban academic medical center; massage therapy was provided in patients' homes. SUBJECTS: Subjects were patients with metastatic cancer. INTERVENTIONS: There were three interventions: massage therapy, no-touch intervention, and usual care. OUTCOME MEASURES: Primary outcomes were pain, anxiety, and alertness; secondary outcomes were quality of life and sleep. RESULTS: In this study, it was possible to provide interventions for all patients at home by professional massage therapists. The mean number of massage therapy sessions per patient was 2.8. A significant improvement was found in the quality of life of the patients who received massage therapy after 1-week follow-up, which was not observed in either the No Touch control or the Usual Care control groups, but the difference was not sustained at 1 month. There were trends toward improvement in pain and sleep of the patients after therapeutic massage but not in patients in the control groups. There were no serious adverse events related to the interventions. CONCLUSIONS: The study results showed that it is feasible to provide therapeutic massage at home for patients with advanced cancer, and to randomize patients to a no-touch intervention. Providing therapeutic massage improves the quality of life at the end of life for patients and may be associated with further beneficial effects, such as improvement in pain and sleep quality. Larger randomized controlled trials are needed to substantiate these findings.

Medical Subject Headings (MeSH)
AdultAgedBostonFeasibility StudiesFemaleFollow-Up StudiesHome Care ServicesHumansMaleMassageMiddle AgedNeoplasm MetastasisPain MeasurementQuality of LifeSleep
Study Links
Quality Scores
Safety90
Efficacy75/10
Quality80/10
Citation Metrics
Total Citations33
Citations/Year2.8
Relative Citation Ratio1.39
NIH Percentile62.3%
Research Impact Scores
APT Score0.75
Weight Score1.58
Normalized Score0.82
Related Supplements